READ-ONLY DIGITIZATION RESULT
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study.
Blood · 2025-Jun-12 · PMID 40090011
Panel B质量警告待 EXE 对齐验证
Time to first use of rescue therapy
Figure 3. Time to event analyses. Kaplan-Meier plot of time to first platelet count of ≥50 × 10 9 /L or ≥30 × 10 9 /L and doubled from baseline (A) and time to first use of rescue therapy (B) during the 24-week double-blind period. Cox regression model was used with treatment group and stratification factors as covariates. Log-rank test was adjusted by stratification factors.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | quality_warning | 待验证 | 1 | 2026-07-23T18:08:23+00:00 |